CSF3 probably counteracts fibrosis, as high expression levels have been correlated with reduced ECM deposition in the liver, and its administration in bleomycin-affected mice resulted in the amelioration of pulmonary fibrosis (154, 155). The gene discussed is CSF3; the disease is pulmonary fibrosis.